Covidien Announces R&D Center in China

Covidien

, a leading global provider of healthcare products, today announced the creation of its flagship research and development (R&D) center for China, which will be based in Shanghai. The center, which will be fully functional by July 2012, will house two of Covidien's emerging market R&D organizations: Tailored Products – will identify and develop products that are customized to meet the needs of China and other countries in the emerging markets Breakthrough Platforms – will utilize the unique skill sets and expertise of employees in Asia to create and develop new medical device technologies. “The establishment of this R&D facility is a first for Covidien in China,” said Dr. Dong Wu, Vice President, China R&D, Covidien. “We will be undertaking a range of cutting-edge activities that will create innovative products to help physicians improve the health of the people of China and of other markets worldwide.”